While cardiac hypertrophy elicited by pathological stimuli eventually leads to cardiac dysfunction, exercise-induced hypertrophy does not. This suggests that a beneficial hypertrophic phenotype exists. In search of an underlying molecular substrate we used microarray technology to identify cardiac gene expression in response to exercise. Rats exercised for seven weeks on a treadmill were characterized by invasive blood pressure measurements and echocardiography. RNA was isolated from the left ventricle and analysed on DNA microarrays containing 8740 genes. Selected genes were analysed by quantitative PCR. The exercise program resulted in cardiac hypertrophy without impaired cardiac function. Principal component analysis identified an exercise-induced change in gene expression that was distinct from the program observed in maladaptive hypertrophy. Statistical analysis identified 267 upregulated genes and 62 downregulated genes in response to exercise. Expression changes in genes encoding extracellular matrix proteins, cytoskeletal elements, signalling factors and ribosomal proteins mimicked changes previously described in maladaptive hypertrophy. Our most striking observation was that expression changes of genes involved in b-oxidation of fatty acids and glucose metabolism differentiate adaptive from maladaptive hypertrophy. Direct comparison to maladaptive hypertrophy was enabled by quantitative PCR of key metabolic enzymes including uncoupling protein 2 (UCP2) and fatty acid translocase (CD36). DNA microarray analysis of gene expression changes in exercise-induced cardiac hypertrophy suggests that a set of genes involved in fatty acid and glucose metabolism could be fundamental to the beneficial phenotype of exercise-induced hypertrophy, as these changes are absent or reversed in maladaptive hypertrophy.Abbreviations ACE, angiotensin converting enzyme; ALP, actinin a2 associated LIM protein; EST, expressed sequence tag; FABP4, fatty acid binding protein 4; FACL, fatty acid CoA ligase; FDR, false discovery rate; GCKR, glucokinase regulatory protein; HR, heart rate; LVEDP, left ventricular end diastolic pressure; MAP, mean arterial pressure; MBE, model based expression; MYL, fast myosin alkali light chain; PCA, principal component analysis; PDC, pyruvate dehydrogenase complex; PDP, pyruvate dehydrogenase phosphatase; Slc27a1, fatty acid transport protein 4; UCP2, uncoupling protein 2.

No abstract